Vicore Pharma: Restoring lung function for IPF patients
Dec 12, 2023•11 min•Ep. 13
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Hear Vicore Pharma’s CEO, Ahmed Mousa speak to Optimum's Richard Staines on their new treatment for Idiopathic Pulmonary Fibrosis (IPF), C21. It aims to improve available treatments for patients of IPF by halting the progression of fibrosis and has the aim of restoring lung function.
Hosted on Acast. See acast.com/privacy for more information.
For the best experience, listen in Metacast app for iOS or Android